Thomas Illig is re-elected to the GBN Board of Directors

16.12.2026

The German Biobank Network (GBN) has elected a new 12-member Steering Committee (SC) for the 2026-2027 term of office.

The SC regularly discusses the interests of the network and makes decisions on further development.

The following candidates were elected by the GBA's partner and observer biobanks

• Dr. Heidi Altmann (BioBank Dresden), 
• Dr. Gabriele Anton (Biobank Ostwestfalen-Lippe der Universität Bielefeld), 
• Dr. Ronny Baber (Leipzig Medical Biobank), 
• Dr. Alexander Brobeil (BioMaterialBank Heidelberg),
• Dr. Daniel Brucker (Interdisziplinäre Biomaterial- und Datenbank Frankfurt), 
• Prof. Dr. Thomas Illig (Hannover Unified Biobank), 
• Prof. Dr. Roland Jahns (Interdisziplinäre Biomaterial- und Datenbank Würzburg), 
• PD Dr. Dr. Michael Kiehntopf (Integrierte Biobank Jena), 
• Dr. Romy Kirsten (Integrierte Biobank Mannheim), 
• Prof. Dr. Alexandra Nieters (Freeze-Biobank Freiburg), 
• PD Dr. Sara Nußbeck (Zentrale Biobank UMG Göttingen) und
• Dr. Alexandra Stege (Zentrale Biobank Charité/BIH Berlin).